BIOLOGY
纳安生物
Project
Product Code
Therapeutic and diagnostic areas
Dosage Form
Pre-clinical
Clinical approval document for preparation production
Clinical trial
T320-ADC
Cervical cancer, lung cancer, pancreatic cancer
Intravenous injection
Clinical approval documents for preparation production
T330-ADC
Lung cancer, pancreatic cancer, cervical cancer
Intravenous injection
Preclinical
Dual anti-B830-ADC
Lung cancer, pancreatic cancer, esophageal cancer
Intravenous injection
Preclinical
Double anti-B836-ADC
Breast cancer, colorectal cancer, stomach cancer
Intravenous injection
Preclinical
Double anti-B837-ADC
Colorectal cancer, lung cancer, breast cancer
Intravenous injection
Preclinical
Double anti-B8571-ADC
Lung cancer, stomach cancer, breast cancer
Intravenous injection
Preclinical
Double anti-B8572-ADC
Lung cancer, stomach cancer, breast cancer
Intravenous injection
Preclinical
Double anti-B867-ADC
Malignant solid tumor
Intravenous injection
Preclinical
Double anti-B859-ADC
Stomach cancer, breast cancer, pancreatic cancer
Intravenous injection
Preclinical
N530-ADC
Lung cancer, cervical cancer, ovarian cancer
Non-injectable preparations
Preclinical
N560-ADC
Lung cancer, cervical cancer, ovarian cancer
Non-injectable preparations
Preclinical
Concomitant diagnosis T320
Malignant solid tumor
Diagnostic reagents
Clinical approval documents for preparation production
NanoPan1-4
Diagnosis of pancreatic function
Diagnostic reagents
Preclinical
NanoLattix-6
Early cancer screening annual examination
Compound annual inspection
Preclinical
